Institution
Cardiovascular Institute of the South
Other•Houma, Louisiana, United States•
About: Cardiovascular Institute of the South is a other organization based out in Houma, Louisiana, United States. It is known for research contribution in the topics: Myocardial infarction & Population. The organization has 6744 authors who have published 6131 publications receiving 175736 citations.
Topics: Myocardial infarction, Population, Heart failure, Coronary artery disease, Percutaneous coronary intervention
Papers published on a yearly basis
Papers
More filters
Harvard University1, Novartis2, University of Melbourne3, Charité4, University of Göttingen5, University of Oslo6, Rabin Medical Center7, National Yang-Ming University8, University of Barcelona9, National Institutes of Health10, Robertson Centre for Biostatistics11, University of Cyprus12, National and Kapodistrian University of Athens13, University of Zurich14, National University of San Marcos15, Cardiovascular Institute of the South16, Katholieke Universiteit Leuven17, Copenhagen University Hospital18, Medical University of Łódź19, Karolinska University Hospital20, Montreal Heart Institute21, Semmelweis University22, University Hospital Centre Zagreb23, Seoul National University Hospital24, Nara Medical University25, Pontifícia Universidade Católica de Campinas26, Northwestern University27, University of Belgrade28, University of Arizona29, Carol Davila University of Medicine and Pharmacy30, Ljubljana University Medical Centre31, First Faculty of Medicine, Charles University in Prague32, Cumhuriyet University33, Tongji University34, University of Graz35, University of Minnesota36, Fudan University37, National University of Singapore38, Baylor University Medical Center39, Brigham and Women's Hospital40, Mayo Clinic41, University Medical Center Groningen42, University of Lorraine43, Medical University of South Carolina44, British Heart Foundation45
TL;DR: PARAGON-HF represents a contemporary group of patients with HFpEF with similar age and sex distribution compared with priorHFpEF trials but higher prevalence of comorbidities, and insights into the impact of inclusion criteria on, and regional variation in, HFp EF patient characteristics are provided.
Abstract: Background: To describe the baseline characteristics of patients with heart failure and preserved left ventricular ejection fraction enrolled in the PARAGON-HF trial (Prospective Comparison of Angi...
111 citations
TL;DR: There is a convincing body of evidence that race continues to matter in the health system, but a nationally representative survey of physicians revealed that the majority of physicians do not view a patient's race/ethnicity as a factor in obtaining care, but do believe insurance coverage matters.
111 citations
TL;DR: High-density lipoprotein inflammatory index has less anti-inflammatory capacity as assessed by HII in the setting of ACS compared with controls or subjects with chronic CAD.
111 citations
TL;DR: The presence of gHTN, EF ≥ 35% at diagnosis, breastfeeding, and postpartum diagnosis were all significantly associated with recovery of systolic function, suggesting internet recruitment may be a valuable tool for studying PPCM.
111 citations
TL;DR: Rotational atherectomy remains a useful niche device for the percutaneous treatment of such complex lesions, usually as an adjunct to subsequent balloon angioplasty and/or intracoronary stent placement.
Abstract: Despite the increasing use of percutaneous transluminal coronary angioplasty and intracoronary stent placement for the treatment of obstructive coronary artery disease, a large subset of coronary lesions cannot be adequately treated with balloon angioplasty and/or intracoronary stenting alone. Such lesions are often heavily calcified or fibrotic and undilatable with the present balloon technology and attempts to treat them with balloon angioplasty or intracoronary stent placement often lead to vessel dissection or incomplete stent deployment with resultant adverse outcomes. Rotational atherectomy remains a useful niche device for the percutaneous treatment of such complex lesions, usually as an adjunct to subsequent balloon angioplasty and/or intracoronary stent placement. In contrast to balloon angioplasty or stent placement that widen the coronary lumen by displacing atherosclerotic plaque, rotational atherectomy removes plaque by ablating the atherosclerotic material, which is dispersed into the distal coronary circulation. Other lesion subtypes amenable to treatment with this modality include ostial and branch-ostial lesions, chronic total occlusions, and in-stent restenosis. This review discusses the technique and principles of rotational atherectomy, the various treatment strategies for its use (including adjunctive pharmacotherapy), the lesion-specific applications for this device, and the complications unique to this modality. Recommendations are also made for its use in the current interventional era.
111 citations
Authors
Showing all 6768 results
| Name | H-index | Papers | Citations |
|---|---|---|---|
| Eric J. Topol | 193 | 1373 | 151025 |
| Peter W.F. Wilson | 181 | 680 | 139852 |
| Aaron R. Folsom | 181 | 1118 | 134044 |
| Valentin Fuster | 179 | 1462 | 185164 |
| Ramachandran S. Vasan | 172 | 1100 | 138108 |
| Michael Snyder | 169 | 840 | 130225 |
| Daniel J. Rader | 155 | 1026 | 107408 |
| Ronald W. Davis | 155 | 644 | 151276 |
| Michael A. Matthay | 151 | 998 | 98687 |
| Robert O. Bonow | 149 | 808 | 114836 |
| Roxana Mehran | 141 | 1378 | 99398 |
| Jonathan L. Halperin | 133 | 486 | 121655 |
| Gerald M. Reaven | 133 | 799 | 80351 |
| Roberto Ferrari | 133 | 1654 | 103824 |
| Gregg W. Stone | 132 | 1299 | 65531 |